Prodigiosin is a bioactive tricyclic tripyrrole pigment produced by various bacteria, most notably Serratia marcescens, that belongs to the prodiginine family of secondary metabolites. Although not currently… Read more
Prodigiosin is a bioactive tricyclic tripyrrole pigment produced by various bacteria, most notably Serratia marcescens, that belongs to the prodiginine family of secondary metabolites. Although not currently approved as a therapeutic drug for human use, this compound is extensively investigated in research settings for its potential antimicrobial, immunosuppressive, and anticancer properties. Laboratories working with this compound require high-quality reference standards for rigorous analytical testing and method development. This category provides essential materials, including prodigiosin derivatives, known impurities, and stable isotope-labelled compounds, which are critical for accurate impurity profiling and quantitation. Researchers utilize these reference materials during method validation and stability studies to ensure the precise identification and quantification of prodigiosin in complex matrices, supporting the development of biotechnological applications and the broader study of its pharmacological potential.